TrialThe Journal of infectious diseases2022

Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults.

Joseph Eiden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.